ISRCTN11216093已完成不适用
tility of serum and platelet levels of Brain- Derived Neurotrofic Factor (BDNF) like biological marker of treatment response in major depression: a longitudinal controlled trial
Hospital Clinic of Barcelona (Hospital Clínic de Barcelona) (Spain)0 个研究点目标入组 32 人开始时间: 2010年6月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patient group:
- •1.1. Patients suffering from a current major depressive episode, single episode or recurrent, diagnosed according to Diagnostic and Statistical Manual for Mental Disorders Criteria
- •1.2. A 17-item Hamilton Depression Rating Scale (HDRS) total score of 18 or higher.
- •1.3. Aged between 18 and 65 years
- •2. Control group:
- •2.1. Healthy subjects with no history of chronic physical illness, substance abuse or mental diseases and not taking regular medications in the last month were recruited
- •2.2. Free of chronic and acute physical illness within the 2 weeks before the study
- •2.3. Aged between 18 and 65 years
- •3. Written information was given and written informed consent was obtained from each patient to participate
排除标准
- •1. Patient group:
- •1.1. Presence of other major axis I disorders, including schizophrenia, bipolar disorders, anxiety disorders, substance-related disorders and eating disorders
- •1.2. Presence of any acute physical disorders and/or exposure to any psychotropic drugs in the last month
- •2. Control group
- •2.1. History of chronic physical illness, substance abuse or mental diseases or taking regular medications in the last month
- •2.2. Free of chronic and acute physical illness within the 2 weeks before the study
研究者
相似试验
已完成
不适用
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinibJPRN-UMIN000004703Osaka City University10
已完成
4 期
Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol following intravenous and oral administratioACTRN12615000322538Royal Melbourne Hospital21
已完成
不适用
An observational study of serum and cerebrospinal fluid concentrations of osimertinib for the treatment of lung cancer harboring EGFR activating and T790M mutations.ung CancerJPRN-UMIN000024327Miyagi Cancer Center40
尚未招募
不适用
Platelet trends in malariaCTRI/2020/05/025468Akilesh S
进行中（未招募）
4 期
Evaluation of concentrations in hemacea, plasma and total magnesium in patients submitted to chemotherapy with platinum compounds in association with proton pump inhibitors and their correlation with neurological diseaseseoplasmsMalignant neoplasm of other parts of pancreasMalignant neoplasm of rectumMalignant neoplasm of splenic flexureMalignant neoplasm of main bronchusUndescended testisMalignant neoplasm of ovaryHodgkin's diseaseMalignant neoplasm of head, face and neckMalignant neoplasm of breastIdiopathic peripheral autonomic neuropathyRBR-8vsb7k2IVERSIDADE FEDERAL DO RIO GRANDE DO NORTE